Dabur India Ltd Q3 FY25 Results: Net Profit Rises 1.8% to ₹515.82 Crore and FMCG Growth
Dabur India Ltd: Overview
Dabur India Ltd. is one of India’s leading consumer goods companies with a strong presence in the FMCG (Fast-Moving Consumer Goods) sector. Established in 1884, the company is known for its Ayurvedic and natural healthcare products. It has a diversified portfolio across healthcare, personal care, home care, and food & beverages. With a strong distribution network spanning India and global markets, Dabur has solidified its position as a key player in the industry. The company’s primary offerings include well-known brands such as Dabur Chyawanprash, Dabur Honey, Dabur Amla, Vatika, and Real fruit juices, all of which have established themselves as household names across India and in international markets. Dabur is particularly distinguished by its focus on leveraging Ayurvedic knowledge and natural ingredients in its product formulations, positioning itself as a pioneer in the Ayurvedic FMCG sector. With a significant presence in over 100 countries, Dabur has expanded its footprint globally, especially in markets such as the Middle East, Africa, and Southeast Asia, capitalizing on the increasing global demand for herbal, organic, and wellness-focused products. The company also invests heavily in research and development to ensure innovation and high-quality standards in its offerings. Dabur’s ability to adapt to changing consumer preferences, coupled with its strong distribution network, has enabled it to maintain a competitive edge in the fast-growing FMCG market. The company operates in over 120 countries, with significant revenue contributions from the Middle East, Africa, South Asia, and the United States.
Latest Stock News
Dabur has reported strong performance across various segments in the recent quarter. In oral care, both the Red franchise and Meswak brands performed well, continuing to gain market share. The gels portfolio within the “freshness” segment saw double-digit growth. In hair care, hair oils grew by 3.1%, gaining 150 basis points in market share, while the shampoo category outperformed the overall market and gained approximately 20 basis points. In homecare, Odonil achieved double-digit volume growth, with its aerosol and gel variants performing particularly well, resulting in a 101 basis point market share gain in air fresheners. On the other hand, Odomos faced a muted performance due to a slowdown in the category but outperformed the segment and gained 574 basis points in the MRC segment. Sanifresh also posted double-digit growth. In skincare, the Gulabari franchise showed strong performance with high single-digit growth. In health supplements, unfavourable weather conditions impacted performance, though Chyawanprash continued to lead the market and gained 139 basis points in market share. Digestives saw Hajmola achieve mid-single-digit growth in both candy and tablet formats, with extensions and variants contributing over 15% to the franchise. In OTC & Ethicals, key brands like Honitus, Shilajit, health juices, and women’s health tonics performed well. In foods, the segment maintained its growth momentum with a 30% year-on-year increase, driven by key categories such as homemade paste, coconut milk, oil & ghee, tomato puree, and Lemoneez. Badshah also continued its strong growth trajectory, recording double-digit volume growth and market share gains. Beverages faced challenges in the J&N category due to muted festive season demand and increased competitive intensity driven by price changes. Real gained 318 basis points in market share, with several internal initiatives planned to accelerate future growth.
Business Segments
- Health Care: It includes many product categories in its portfolio like Dabur Chyawanprash, Honey, Pudin Hara, Dabur Lal Tail, etc. which is huge brands in India and they all are used for consumers’ health benefits and healthy routines. This segment is a core business contributes about 31-35% of Dabur’s revenue.
- Personal Care: It is used by many consumers as daily routine for their personal care, the products like Dabur Amla, Dabur Red Paste, and Vatika. And there are other international brands of Dabur which has presence outside India for personal care, oral care, skin or hair care, etc.
- Food & Beverages: This segment includes a very popular packaged soft drink brand called Real, its yearly turnover is more than ₹1000 crore. And the Badshah Masala brand, which is a huge private company is acquired 51% stake for ₹590 crore.
- Geography: The international business accounts for almost 25% revenue of the company. The geography distribution of International market is Middle East- 24%, Africa- 24%, Europe- 15%, America- 15% and Asia-22%.
Subsidiary Information
- Dabur International Ltd: Dabur International Ltd. is one of the key subsidiaries of Dabur India, responsible for the company’s operations in international markets. The subsidiary focuses on the production and marketing of Dabur’s range of health, personal care, and food products in these regions. Its product portfolio includes hair oils, skincare products, and Ayurvedic health supplements, with a strong emphasis on natural and herbal offerings.
- Dabur Nepal Pvt Ltd: Dabur Nepal Pvt Ltd. is a wholly-owned subsidiary of Dabur India that serves as a vital part of Dabur’s operations in Nepal. The company is responsible for managing Dabur’s products in Nepal and acts as a strategic hub for the regional markets. Dabur Nepal manufactures and markets a variety of products, including Ayurvedic medicines, personal care, and food items, catering to the local market’s demands.
- Dabur Egypt Ltd: Dabur Egypt Ltd. operates as Dabur India’s subsidiary in Egypt, focusing on expanding the company’s footprint in the North African region. The subsidiary markets a broad spectrum of Dabur products, including hair care products, skin care items, and health supplements, catering to local consumer needs. Dabur Egypt has leveraged its expertise in Ayurveda to introduce products that align with regional preferences for natural and herbal ingredients.
- Hamdard Laboratories (India): Hamdard Laboratories (India) is a well-known subsidiary of Dabur India, following Dabur’s acquisition of a controlling stake in the company. Hamdard Laboratories is a key player in the herbal healthcare market and operates under the Hamdard brand, which has a strong reputation for its traditional Unani medicines and herbal products.
- Dabur India Ltd. (Turkey): Dabur India Ltd. also operates in Turkey through its subsidiary, Dabur Turkey, where it primarily focuses on marketing and distributing health, personal care, and food products. Dabur Turkey aims to provide consumers with a wide range of herbal and Ayurvedic products that align with the growing global demand for natural wellness.
Q3 FY25 Earnings
- Revenue of ₹3355 crore in Q3 FY25 up by 3.08% YoY from ₹3255 crore in Q3 FY24.
- EBITDA of ₹682 crore in this quarter at a margin of 20% compared to 20% in Q3 FY24.
- Profit of ₹516 crore in this quarter compared to a ₹506 crore profit in Q3 FY24.
Financial Summary
| Amount in ₹ Cr | Q3 FY24 | Q3 FY25 | FY23 | FY24 |
| Revenue | 3255 | 3355 | 11530 | 12404 |
| Expenses | 2588 | 2673 | 9367 | 10004 |
| EBITDA | 667 | 682 | 2162 | 2400 |
| OPM | 20% | 20% | 19% | 19% |
| Other Income | 127 | 129 | 445 | 482 |
| Net Profit | 506 | 516 | 1701 | 1811 |
| NPM | 15.5% | 15.4% | 14.8% | 14.6% |
| EPS | 2.9 | 2.95 | 9.6 | 10.4 |